Free 7-day Trial
All Articles and Columns »

M.D.C. Holdings Inc. (MDC) President, COO and Director David D Mandarich sells 25,000 Shares

August 06, 2012 | About:
insider

insider

52 followers
President, COO and Director of M.D.C. Holdings Inc. (MDC) David D Mandarich sells 25,000 shares of MDC on 08/03/2012 at an average price of $31.94 a share.

M.d.c. Holdings, Inc. has a market cap of $1.53 billion; its shares were traded at around $31.8 with and P/S ratio of 1.8. The dividend yield of M.d.c. Holdings, Inc. stocks is 3.1%.


This is the insider trade history vs. stock price of MDC. For the complete insider trading history of MDC, click here.




Directors and Officers Recent Trades:



  • Director Michael A Berman sold 15,000 shares of MDC stock on 08/03/2012 at the average price of 32.4. Michael A Berman owns at least 10,000 shares after this. The price of the stock has decreased by 1.85% since.
  • Director Herbert T Buchwald sold 9,325 shares of MDC stock on 08/02/2012 at the average price of 31.9. Herbert T Buchwald owns at least 16,948 shares after this. The price of the stock has decreased by 0.31% since.
  • President, COO and Director David D Mandarich sold 50,000 shares of MDC stock on 08/02/2012 at the average price of 31.95. David D Mandarich owns at least 3,036,731 shares after this. The price of the stock has decreased by 0.47% since.
  • President, COO and Director David D Mandarich sold 50,000 shares of MDC stock on 08/01/2012 at the average price of 31.88. David D Mandarich owns at least 3,036,731 shares after this. The price of the stock has decreased by 0.25% since.


For the complete insider trading history of MDC, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide